LONG-TERM RESULTS OF BRONCHOPLASTIC SURGICAL INTERVENTIONS IN COMPARISON WITH PNEUMONECTOMIES IN LUNG CANCER
##article.numberofdownloads## 64
##article.numberofviews## 104
PDF (Русский)

Keywords

LUNG CANCER
LONG-TERM RESULTS
BRONCHOPLASTIC SURGICAL INTERVENTIONS
PNEUMONECTOMY

How to Cite

Levchenko, Y., Mikhnin, A., Yergnyan, S., Barchuk, A., Gorokhov, L., Slugin, Y., Grinkevich, M., Levchenko, Y., & Yurin, R. (2017). LONG-TERM RESULTS OF BRONCHOPLASTIC SURGICAL INTERVENTIONS IN COMPARISON WITH PNEUMONECTOMIES IN LUNG CANCER. Voprosy Onkologii, 63(2), 234–239. https://doi.org/10.37469/0507-3758-2017-63-2-234-239

Abstract

The analysis of long-term results of surgical treatment of 198 patients with non-small cell lung cancer (NSCLC) I -III stages. Bronchoplasty (BP) interventions were performed in 99 cases, the control group comprised 99 patients after pneumonectomies (PE) corresponding to the main prognostic criteria for patients after BP interventions. A 1-year, 3-year and 5-year observed survival rates of patients were 87.7%, 56.2% and 44.6% after BP versus 82.8%, 54.6% and 35.9% after PE, respectively. A 1-year, 3-year and 5-year disease-free survival in the BP group was 87.9%, 64.2% and 52.3% versus 88.1%, 61.6% and 37.9% in the PE group. The median of overall and disease-free survival was 51.4 and 55.2 months in the BP group versus 46.2 and 41.0 months in the PE group, respectively.
https://doi.org/10.37469/0507-3758-2017-63-2-234-239
##article.numberofdownloads## 64
##article.numberofviews## 104
PDF (Русский)

References

Мерабишвили В.М., Дятченко О.Т. Статистика рака легкого (заболеваемость, смертность, выживаемость) // Практическая онкология. - 2000. - № 3. - С. 3-7.

Bagan P., Berna P, Pereira J.C. et al. Sleeve lobectomy versus pneumonectomy: tumor characteristics and comparative analysis of feasibility and results // Ann. Thorac. Surg. - 2005. - Vol. 80. - P. 2046-2050.

Berry M.F., Worni M., Wang X. et al. Sleeve Lobectomy for Non-Small Cell Lung Cancer With N1 Nodal Disease Does Not Compromise Survival // Ann. Thorac. Surg. - 2014. - Vol. 97. - P 230 - 235.

Bogot N.R., Quint L.E. Imaging of recurrent lung cancer // Cancer Imaging. - 2004. - Vol. 4. - № 2. - P. 61-67.

Deslauriers J., Gregoire J., Jacques L.F. et al. Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences // Ann. Thorac. Surg. - 2004. - Vol. 77. - P. 1152 -1156.

Gaissert H.A., Mathisen D.J., Moncure A.C. et al. Survival and function after sleeve lobectomy for lung cancer // J. Thorac. Cardiovasc. Surg. - 1996. - Vol. 11. - P. 948 - 953.

Ghiribelli C., Voltolini L., Luzzi L. et al. Survival after bronchoplastic lobectomy for non-small cell lung cancer compared with pneumonectomy according to nodal status // J. Cardiovasc. Surg. - 2002. - Vol. 43. - P. 103 - 108.

Kim YT., Kang C.H., Sung S.W., Kim J.H. Local control of disease related to lymph node involvement in nonsmall cell lung cancer after sleeve lobectomy compared with pneumonectomy // Ann. Thorac. Surg. - 2005. - Vol. 79. - P. 1153 - 1161.

Ludwig C., Stoelben E., Olschewski M., Hasse J. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma // Ann. Thorac. Surg. -2005. - Vol. 79. - P. 968 - 975.

Okada M., Yamagishi H., Stake S. Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy // J. Thorac. Cardiovasc. Surg. - 2000. - Vol. 119. - P. 814 - 819.

Parissis H., Leotsinidis M., Hughes A. Comparative analysis and outcomes of sleeve resection versus pneumonectomy // Asian Cardiovasc. Thorac. Ann. - 2009. - Vol. 17. - № 2. - P. 175 - 182.

Takeda S., Maeda H., Koma M. et al. Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer: trends over time and 20-year institutional experience // Eur. J. Cardiothorac. Surg. - 2006. - Vol. 29. - № 3. - P 276.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2017